Pharmacogenetic research activity in Central America and the Caribbean: a systematic review

C Cespedes-Garro, MEG Naranjo… - …, 2016‏ - Taylor & Francis
Aim: The present review was aimed at analyzing the pharmacogenetic scientific activity in
Central America and the Caribbean. Materials & methods: A literature search for …

Tyrosine kinase inhibitor sensitive PDGFRΑ mutations in GIST: Two cases and review of the literature

PA Boonstra, JA Gietema, AJH Suurmeijer… - …, 2017‏ - pmc.ncbi.nlm.nih.gov
Gastrointestinal stromal tumors (GISTs) are rare mesenchymal malignancies of the
gastrointestinal tract. Most GISTs harbor a c-KIT (80%) or a PDGFRα (10%) mutation that …

Molecular analysis of the KIT gene in gastrointestinal stromal tumors with novel mutations

G Calibasi, Y Baskin, H Alyuruk, L Cavas… - Applied …, 2014‏ - journals.lww.com
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the
gastrointestinal tract. KIT gene mutations have great importance for GISTs. This study …

Gastrointestinal stromal tumor: genotype frequency and prognostic relevance

N Kumari, V Priyaa, P Shukla, A Kumar… - Applied …, 2018‏ - journals.lww.com
Background: Genoty** has an important role in the prognosis and prediction of response
to tyrosine kinase inhibitor therapy. KIT exon 11 deletions serve as an adverse prognostic …

Somatic mutational spectrum analysis in a prospective series of 104 gastrointestinal stromal tumors

D Guenat, O Deroo, S Magnin… - Oncology …, 2017‏ - spandidos-publications.com
Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors distinguished by driver
mutations in proto-oncogenes KIT or PDGFRA in 85-90% of cases. These mutations have …

Analysis of clinicopathologic features and gene mutations in gastrointestinal stromal tumor: a series of 58 patients

H Cheng, T Qiu, SS Shi - International Journal of Clinical and …, 2021‏ - pmc.ncbi.nlm.nih.gov
Background: In gastrointestinal stromal tumor (GIST), mutually exclusive gain-of-function
mutations of c-kit and PDGFRα are associated with different mutation-dependent clinical …

Frequency of KIT mutation in gastrointestinal stromal tumors according to histologic and immunohistochemical findings, the first report from Iran

B Geramizadeh, Z Jowkar… - Iranian Journal of Medical …, 2015‏ - pmc.ncbi.nlm.nih.gov
Background Gastrointestinal stromal tumor (GIST) is the most common mesenchymal
neoplasm of the gastrointestinal tract. They are believed to originate from the interstitial cells …

Molecular and immunohistochemical study of platelet derived growth factor receptor alpha in KIT negative gastrointestinal stromal tumors; the first report from Iran

B Geramizadeh, Z Jowkar… - Middle East Journal of …, 2016‏ - pmc.ncbi.nlm.nih.gov
BACKGROUND Gastrointestinal stromal tumors (GISTs) are potentially malignant tumors;
however their behavior and response to treatment is dependent on the type of mutation and …

[PDF][PDF] The frequencies of c-kit proto-oncogene (KIT) mutations in gastrointestinal stromal tumours: a population based study from Aegean Region of Turkey

G Çalıbaşı - Türk Biyokimya Dergisi [Turkish Journal of …, 2013‏ - academia.edu
Objectives: The c-kit proto-oncogene (KIT) exon 9, 11, 13 and 17 activation mutations are
associated with clinical behaviour in gastrointestinal stromal tumors with highly variable …

Clinicopathological Features and Gene Mutation Analysis of Gastrointestinal Stromal Tumors: A Series of 58 Patients

T Qiu, S Shi - 2021‏ - researchsquare.com
[Background] In gastrointestinal stromal tumors (GISTs), mutually exclusive gain-of-function
mutations of KIT and PDGFRA are associated with different mutation-dependent clinical …